Prosecution Insights
Last updated: May 29, 2026

Nanjing Nutrabuilding Bio-Tech Co. Ltd.

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (80%)
0
Easy (0%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only4 (80%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, SEONG JONG 1
ULLMAN, AARON RAFANAN 1
RAHMANI, NILOOFAR 1 77.3% -2.9%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
ISMAIL, REHANA 1 78.9% +30.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18172020 SOFT CAPSULE COMPRISING B-HYDROXYBUTYRIC ACID SCOTLAND, REBECCA LYNN 103d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17975028 USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING ISMAIL, REHANA 33d

Top Art Units

Art UnitApps
1621 1
1628 1
1691 1
1615 1
1625 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18422930 L-ERGOTHIONEINE AND USES THEREOF KIM, SEONG JONG 1621 §103 Non-Final OA 22d Pending Jan 25, 2024
18392229 USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED VISUAL DEGENERATION ULLMAN, AARON RAFANAN 1628 §103 Non-Final OA 34d Pending Dec 21, 2023
18514875 METHODS FOR AMELIORATING AND PREVENTING AGE-RELATED MUSCLE DEGENERATION RAHMANI, NILOOFAR 1691 Other Non-Final OA 2d overdue Pending Nov 20, 2023
18172020 SOFT CAPSULE COMPRISING B-HYDROXYBUTYRIC ACID SCOTLAND, REBECCA LYNN 1615 §103 Non-Final OA 103d overdue Pending Feb 21, 2023
17975028 USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING ISMAIL, REHANA 1625 §103 Final Rejection 33d Pending Oct 27, 2022

Managing Nanjing Nutrabuilding Bio-Tech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month